COMP <GO>
ALHC vs MRK // ALTMAN Z-SCORE & DEBT/EQUITY
Alignment Healthcare Inc. (NASDAQ) VS. Merck & Company Inc. (NYSE) • 15-METRIC TALLY: ALHC 2
— MRK 9
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: MRK
LAST: $8.06 (-1.47%) • MKT CAP: $1.67B
balance-sheet
4.00
LAST: $146.33 (+3.83%) • MKT CAP: $361.02B
balance-sheet
5.19
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ALHC VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ALHC | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 74.80% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 13.90% | 20.70% | -6.80 | MRK | /roic <GO> |
| EV/EBITDA & P/E Valuation | 37.8x | 15.3x | +22.50 | MRK | /valuation <GO> |
| Free Cash Flow Yield | 6.77% | 3.42% | +3.35 | ALHC | /fcf-yield <GO> |
| Operating Margin | 0.40% | 34.30% | -33.90 | MRK | /operating-margins <GO> |
| Net Profit Margin | 0.00% | 28.10% | -28.10 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | 46.10% | 1.30% | +44.80 | ALHC | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.26% | -2.26 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 4.00 | 5.19 | -1.19 | MRK | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | MRK | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 43.8 | 51.7 | -7.90 | MRK | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.92 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 18.4x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.67B | $361.02B | -$359.35B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ALHC REV | MRK REV | ALHC GROSS % | MRK GROSS % | ALHC FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.95B | $65.01B | — | 74.8% | $113.1M | $12.36B |
| FY 2024 | $2.70B | $64.17B | — | 76.3% | -$6.6M | $18.10B |
| FY 2023 | $1.80B | $60.12B | — | — | -$59.2M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ALHC // BETA —
MRK // BETA 0.92